Publicacións nas que colabora con Loreto Carmona Ortells (16)

2024

  1. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

2021

  1. Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia

    Reumatologia Clinica, Vol. 17, Núm. 3, pp. 150-154

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. High sodium intake is associated with self-reported rheumatoid arthritis: A cross sectional and case control analysis within the SUN cohort

    Medicine (United States), Vol. 94, Núm. 37

  2. Lipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: A systematic review and meta-analysis

    Arthritis and Rheumatology, Vol. 67, Núm. 1, pp. 117-127

2014

  1. Facteur rhumatoïde et réponse aux anti-TNF dans la polyarthrite rhumatoïde: revue systématique et méta-analyse d'études observationnelles

    Revue du Rhumatisme (Edition Francaise), Vol. 81, Núm. 1, pp. 58-68

  2. Observational study of optimization of biologic therapies in rheumatoid arthritis: A single-centre experience

    Rheumatology International, Vol. 34, Núm. 8, pp. 1059-1063

  3. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

    Joint Bone Spine, Vol. 81, Núm. 1, pp. 41-50

  4. Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: A systematic review and meta-analysis of randomized controlled trials and long-term extension studies

    Rheumatology (United Kingdom), Vol. 53, Núm. 10, pp. 1872-1885

  5. Safety profile of protein kinase inhibitors in rheumatoid arthritis: Systematic review and meta-analysis

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 5, pp. 871-882

2013

  1. Le facteur rhumatoïde ne semble pas prédire la réponse aux anti-TNF α dans la polyarthrite rhumatoïde: expérience de trois centres

    Revue du Rhumatisme (Edition Francaise)

  2. Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis

    Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 1, pp. 9-17

  3. Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience

    Joint Bone Spine

2012

  1. Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

    Seminars in Arthritis and Rheumatism, Vol. 42, Núm. 1, pp. 89-103

2009

  1. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 6, pp. 920-925

2003

  1. Patterns of disease modifing antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 30, Núm. 4, pp. 697-704